cysteine and Lymphangiomyomatosis

cysteine has been researched along with Lymphangiomyomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haklai, R; Kloog, Y; Makovski, V	1

Other Studies

1 other study(ies) available for cysteine and Lymphangiomyomatosis

Article	Year
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis. International journal of cancer, 2012, Mar-15, Volume: 130, Issue:6 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine; Farnesol; Lymphangioleiomyomatosis; Lymphocytes, Null; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Mutation; Neuropeptides; Phosphorylation; Ras Homolog Enriched in Brain Protein; ras Proteins; Rats; Ribosomal Protein S6 Kinases; Salicylates; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins	2012

Article

Year

Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.

International journal of cancer, 2012, Mar-15, Volume: 130, Issue:6

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine; Farnesol; Lymphangioleiomyomatosis; Lymphocytes, Null; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Mutation; Neuropeptides; Phosphorylation; Ras Homolog Enriched in Brain Protein; ras Proteins; Rats; Ribosomal Protein S6 Kinases; Salicylates; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

2012